Table I.
Model | Code | R(x) | BMD | Restrictions/Notes |
---|---|---|---|---|
Logistic | 1 | − | ||
Probit | 2 | Φ(β0 + β1x) | QBMR = Φ−1{BMR[1 −Φ(β0)] + Φ(β0)} | |
Quantal-linear | 3 | 1 − exp{−β0 − β1x} | β0 ≥ 0, β1 ≥ 0 | |
Quantal-quadratic | 4 | γ0 + (1−γ0)(1−exp{−β1x2}) | 0 ≤ γ0 ≤ 1, β1 ≥ 0 | |
Two-stage | 5 | 1 − exp{−β0 − β1x − β2x2} | βj ≥ 0, j = 0,1,2 TBMR = −log(1 − BMR) |
|
Log-logistic | 6 | 0 ≤ γ0 ≤ 1, β1 ≥ 0 LBMR = log{BMR/(1−BMR)} |
||
Log-probit | 7 | γ0 + (1−γ0)Φ(β0 + β1log[x]) | 0 ≤ γ0 ≤ 1, β1 ≥ 0 | |
Weibull | 8 | γ0 + (1−γ0)[1–exp{−eβ0xβ1}] | 0 ≤ γ0 ≤ 1, β1 ≥ 1 WBMR = log{−log(1−BMR)} |
Notes: The quantal linear (Model 3) model is also referred to as the ‘one-stage’ model or as the ‘complementary-log’ model, and may equivalently appear as γ0 + (1 − γ0)(1 − exp{−β1x}), where γ0 = 1 − exp{−β0}.
The two-stage model (Model 5) and the quantal-linear/one-stage model (Model 3) are special cases of the more general ‘Multi-stage’ model in carcinogenesis testing (4, §4.2.1).